Jennifer S Yu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Dna Damage Response

Chronic Lymphocytic Leukemia

Top Venues

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiankang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Author Correction: Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Jing Hao, Xiangzi Han, Haidong Huang, Xingjiang Yu, Jiangkang Fang, Jianjun Zhao, Richard A Prayson, Shideng Bao, Jennifer S Yu
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature communications 14 (1) (2023)
Xiaoguang Fang, Zhi Huang, Kui Zhai, Qian Huang, Weiwei Tao, Leo J Y Kim, Qiulian Wu, Alexandru Almasan, Jennifer S Yu, Xiaoxia Li, Srinivasan Dasarathy, Jeremy N Rich, Shideng Bao
Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Science translational medicine 13 (600) (2021)
Yu Shi, Olga A Guryanova, Wenchao Zhou, Chong Liu, Zhi Huang, Xiaoguang Fang, Xiuxing Wang, Cong Chen, Qiulian Wu, Zhicheng He, Wei Wang, Wei Zhang, Tao Jiang, Qing Liu, Yaping Chen, Wenying Wang, Jingjing Wu, Leo J Y Kim, Ryan C Gimple, Hua Feng, Hsiang-Fu Kung, Jennifer S Yu, Jeremy N Rich, Xiu-Wu Bian, Shideng Bao
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. Science translational medicine 10 (443) (2019)
Jing Hao, Jennifer S Yu
Semaphorin 3C and Its Receptors in Cancer and Cancer Stem-Like Cells. Biomedicines 6 (2) (2018)
Jing Hao, Andrew Godley, Jocelyn D Shoemake, Zheyi Han, Anthony Magnelli, Jennifer S Yu
The effects of extra high dose rate irradiation on glioma stem-like cells. PloS one 13 (8) (2018)